Personalized Prehabilitation: A Pathway to Improved Frailty Metrics and Survival in Liver Transplant Candidates
Clinical Gastroenterology and Hepatology · 2026-10
DOI: 10.1016/j.cgh.2026.09.044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-10. Verfasst von Fei-Pi Lin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh, Pittsburgh, Pennsylvania. Die Arbeit nennt 22 Literaturangaben.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
BACKGROUND & AIMS: Outpatient prehabilitation can potentially improve frailty in liver transplant (LT) candidates. Our aim was to determine the impact of prehabilitation on physical fitness and mortality and to identify the minimum clinically important change needed to improve survival. METHODS: In this ambispective cohort study, LT candidates underwent baseline evaluation with a dedicated physical therapist and were prescribed a personalized prehabilitation program based on their functional status. The Liver Frailty Index (LFI), 6-minute walk test (6MWT), and gait speed test (GST) were assessed. Multilevel linear mixed-effects models and multivariable survival analyses were fitted, including competing risks models against LT. RESULTS: A total of 1275 patients (59% male; mean age, 57 ± 11 years; Model for End-stage Liver Disease, 14 ± 6) attended 1973 LT-physical therapist visits. Of these, 355 attended 2 or more follow-up visits, participating in the prehabilitation program. At baseline, the median LFI was 3.8 (interquartile range [IQR], 3.2-4.4), the median 6MWT was 336 meters (IQR, 243-403 meters), and the median GST was 1 (IQR, 0.8-1.2); 23%, 26%, and 29% of the cohort were frail by each tool, respectively. Among subjects who improved the LFI (n = 226/352), the absolute change was -0.39 (IQR, -0.32 to -0.46), and for the 6MWT (n = 212/334), it was 54 meters (IQR, 43-64 meters); fewer than one-half improved the GST. A total of 667 patients (55%) were waitlisted, 462 patients (37%) were transplanted, and 335 patients (26%) died. LFI improvement by at least 0.4 was associated with a ∼50% reduction in mortality (hazard ratio, 0.56; P = .037). Improvement in the 6MWT was not associated with a survival advantage. CONCLUSIONS: Individualized prehabilitation in LT candidates was associated with significant improvement in the LFI and 6MWT. A minimum LFI improvement of 0.4 was associated with improved survival and could be considered a minimal clinically important difference for frailty interventions in LT candidates.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh, Pittsburgh, Pennsylvania.
- Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
- Division of Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh, Pittsburgh, Pennsylvania; Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
- Division of Gastroenterology and Hepatology, Northwestern University, Chicago, Illinois. Electronic address: andres.duarte@northwestern.edu.
Zitieren
APA
Lin, F. P., Bloomer, P. M., Dunn, M. A., Stark, S. A., Hughes, C. B., & Duarte-Rojo, A. (2026). Personalized Prehabilitation: A Pathway to Improved Frailty Metrics and Survival in Liver Transplant Candidates. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2026.09.044
Vancouver
Lin FP, Bloomer PM, Dunn MA, Stark SA, Hughes CB, Duarte-Rojo A. Personalized Prehabilitation: A Pathway to Improved Frailty Metrics and Survival in Liver Transplant Candidates. Clinical Gastroenterology and Hepatology. 2026. doi:10.1016/j.cgh.2026.09.044
BibTeX
@article{Lin2026,
author = {Lin, Fei-Pi and Bloomer, Pamela M and Dunn, Michael A and Stark, Susan A and Hughes, Christopher B and Duarte-Rojo, Andres},
title = {Personalized Prehabilitation: A Pathway to Improved Frailty Metrics and Survival in Liver Transplant Candidates},
journal = {Clinical Gastroenterology and Hepatology},
year = {2026},
doi = {10.1016/j.cgh.2026.09.044}
}
EUVIMED